VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GYRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GYREGyre Therapeutics, Inc.
$7.01$680M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGYREPrice History

GYRE logoGyre Therapeutics, Inc. (GYRE) Stock Price History

Historical prices from 2006 to 2026

$7.01-0.25  (-3.44%)close Jul 7
Returns
1M
+15.9%
3M
-1.5%
YTD
+2.9%
1Y
-8.0%
3Y
+10.1%
5Y
-35.5%
ATH$47,990.25Mar 2011-100.0%
ATL$2.85Mar 2023pre-split
Avg Vol (50D)85K/ day
52-Week Range$5.45 — $9.42
LowCurrent: $7.01High

Loading 10-year price history...

GYRE Historical Performance

1 YearTotal Return
-8.0%
Price: -8.0%
3 YearsTotal Return
+33.5%
CAGR: +10.1%
Price: +33.5%
5 YearsTotal Return
-49.1%
CAGR: -12.6%
Price: -88.9%
YTD
+2.9%

GYRE Annual Returns

Year-by-year price performance · 2006–2026

Best+472.6%2009
Worst-85.2%2021
Up years6/21
2006+4.5%
2007-10.2%
2008-56.7%
2009+472.6%
2010+29.3%
2011-79.2%
2012-22.1%
2013-11.1%
2014-36.8%
2015-82.7%
2016-78.8%
2017+37.8%
2018-45.1%
2019-17.5%
2020-2.9%
2021-85.2%
2022-47.0%
2023+190.3%
2024-49.1%
2025-41.2%
2026+21.0%
2006 annual price return
+4.5%
2007 annual price return
-10.2%
2008 annual price return
-56.7%
2009 annual price return
+472.6%
2010 annual price return
+29.3%
2011 annual price return
-79.2%
2012 annual price return
-22.1%
2013 annual price return
-11.1%
2014 annual price return
-36.8%
2015 annual price return
-82.7%
2016 annual price return
-78.8%
2017 annual price return
+37.8%
2018 annual price return
-45.1%
2019 annual price return
-17.5%
2020 annual price return
-2.9%
2021 annual price return
-85.2%
2022 annual price return
-47.0%
2023 annual price return
+190.3%
2024 annual price return
-49.1%
2025 annual price return
-41.2%
2026 annual price return
+21.0%
LessMore
Alpha vs S&P 500
1Y-35.7%
3Y-8.5%
5Y-24.8%

Price returns only.

Download Historical Data

5,090 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

GYRE Stock Price Trajectory (2006–2026)

As of July 8, 2026, Gyre Therapeutics, Inc. (GYRE) trades at $7.01, representing a -8.0% return over the past year. The stock has delivered a -49.1% total return over five years (-35.5% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $47,990.25 on March 1, 2011. From this peak, GYRE has corrected -100.0%, currently trading 6% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers HALO (+50.4% 1Y), ARDX (+23.7% 1Y), and PRAX (+594.0% 1Y), GYRE has underperformed the peer group average. Compare GYRE vs HALO →

GYRE Historical Price Data · from 2006

Rows 1–50 of 5,090
Date Open High Low Close Volume Change %
2026-07-077.327.326.927.01105K-3.44%
2026-07-067.347.417.047.26132K-1.09%
2026-07-026.727.366.557.34101K+12.58%
2026-07-016.486.596.456.5282K-1.06%
2026-06-306.656.746.346.5953K+2.17%
2026-06-296.466.506.216.4578K+2.54%
2026-06-266.286.496.236.290+0.96%
2026-06-256.536.596.186.2372K-3.86%
2026-06-246.156.696.156.48119K+5.71%
2026-06-236.136.206.116.1352K0.00%
2026-06-226.206.346.096.1374K-1.92%
2026-06-186.206.356.076.2558K+2.80%
2026-06-175.846.135.846.0866K+4.47%
2026-06-165.825.935.745.8275K-0.68%
2026-06-155.956.095.815.8656K-1.18%
2026-06-126.056.065.905.9374K-2.15%
2026-06-115.976.215.956.0675K+1.85%
2026-06-106.096.345.955.9571K-2.94%
2026-06-096.056.195.936.1387K+1.32%
2026-06-086.306.345.956.0576K-3.82%
2026-06-056.606.666.136.29137K+1.62%
2026-06-045.756.295.716.19133K+8.79%
2026-06-035.565.725.535.6969K+2.34%
2026-06-025.805.895.455.56120K-4.30%
2026-06-015.886.025.815.81125K-1.69%
2026-05-295.745.985.745.9167K+2.96%
2026-05-285.925.925.675.7496K-3.04%
2026-05-275.916.035.885.9280K-0.34%
2026-05-266.106.165.875.94126K-1.98%
2026-05-226.226.266.016.0687K-1.94%
2026-05-216.046.225.976.1895K+2.32%
2026-05-206.266.296.016.0495K-3.51%
2026-05-196.426.556.246.2688K-2.80%
2026-05-186.676.706.316.4476K-1.68%
2026-05-156.876.926.556.5594K-6.43%
2026-05-147.247.316.747.00213K-3.85%
2026-05-137.317.437.237.2835K-0.27%
2026-05-127.037.377.037.3050K+2.96%
2026-05-117.407.417.057.0958K-5.09%
2026-05-087.217.477.207.4752K+5.66%
2026-05-077.237.907.017.07167K-12.06%
2026-05-067.888.097.738.04128K+3.34%
2026-05-058.008.007.687.7861K-1.77%
2026-05-047.788.057.737.9273K+1.54%
2026-05-017.687.897.457.8071K+1.56%
2026-04-307.417.707.417.6844K+4.49%
2026-04-297.707.707.307.3544K-4.17%
2026-04-287.707.767.637.6744K+0.52%
2026-04-277.587.657.477.6332K+2.55%
2026-04-247.357.657.347.4432K0.00%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GYRE — Frequently Asked Questions

Quick answers to the most common questions about buying GYRE stock.

How has GYRE stock performed recently?

GYRE declined -8.0% over the past year, below its 5-year annualized CAGR of -35.5%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is GYRE's all-time high price?

Gyre Therapeutics, Inc. reached $47990.25 on 2011-03-01. The 52-week high is $9.42. Current 1-year return of -8.0% places the stock further from historical peaks.

Where can I download GYRE historical price data?

This page provides GYRE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2006-2026, downloadable in CSV format.

464 data points · sampled from 5,090